
News|Articles|August 21, 2006
New product newswire: August 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol. The new inhaler is indicated for long-term maintenance treatment of asthma in patients 12 years of age and older.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
As Pharmacists Enter More Clinical Roles, So Do Pharmacy Technicians | ASHP Midyear 2025
2
Pharmacists Help Patients Manage Insulin Pumps for Type 2 Diabetes | ASHP Midyear 2025
3
Win the Game of Patient Care Through Confidence and Teamwork | ASHP Midyear 2025
4
Reimagining How Pharmacies Deliver Health Care for Patients
5



































































































































